Immunicum AB (publ) Publishes Prospectus in Connection with Rights Issue and Directed Issue
Keep reading
Immunicum AB (publ) Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Ilixadencel in Combination with Avelumab in Multi-Indication Phase Ib/II Study